ArticleJournal of imaging2026
RiTex: Harmonization of Radiomic Features Based on Riemannian Geometry.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Batch effects arising from variations in hardware, acquisition protocols, and reconstruction parameters present a critical challenge in radiomics, limiting the generalizability of models across multicentre studies. Existing harmonization methods, such as ComBat, CovBat, z-score normalization, and Generative Adversarial Networks, exhibit significant limitations when applied to high-dimensional radiomic data. ComBat assumes a linear feature space and tends to leave residual center-specific information recoverable by downstream classifiers. This paper introduces RiTex (Riemannian Texture Harmonization), a framework that solves a generalized eigenvalue problem between class-aware biological scatter and Ledoit-Wolf-regularized per-batch covariances, with the SPD-manifold Fréchet mean used as a principled averaging step. We evaluate RiTex on the 50-dataset radMLBench benchmark and on a new four-center head-and-neck benchmark with known center labels (n = 380 patients, k = 4 centers from TCIA: HGJ, MDACC, Maastro, QIN). On radMLBench, RiTex reduces the batch auto-detection AUC in 48/50 (96%) datasets, 42/50 (84%) reductions remain significant after Benjamini-Hochberg correction; the mean Batch AUC reduction is ΔBatch = -0.365 (95% bootstrap CI [-0.418, -0.312]), with no significant degradation in biological AUC (mean ΔBio = +0.018, 95% CI [-0.011, +0.047]). On the H&N benchmark with real center labels, RiTex reduces the Batch AUC from 0.74 to 0.59, while ComBat and CovBat leave it at ≈0.98. A component-wise ablation shows that the dominant source of empirical performance is the GEVD step, together with Ledoit-Wolf shrinkage. The SPD Fréchet mean acts as a theoretical scaffold with a negligible empirical contribution (ΔBatch AUC = -0.014 vs. arithmetic mean).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.